FANNETTE DOWNIE-ALLMAN: Open Payments
NPI 1952597163 · FORTUNA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 25 payments from 8 companies in 2025. Trend: 2023 $157 · 2024 $192 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $187 |
| Lilly USA, LLC | 11 | $159 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $36 |
| ANI Pharmaceuticals, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $22 |
| Amgen Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: Wegovy, MOUNJARO, JOURNAVX, PURIFIED CORTROPHIN GEL, CREON, Otezla, ZEPBOUND, Ozempic.
Industry payments across CA — which companies pay providers there.
